Asaduddin Owaisi tears copy of Citizenship bill in Lok Sabha amid heated debate

News Network
December 10, 2019

New Delhi, Dec 10: AIMIM president and MP Asaduddin Owaisi tore a copy of the Citizenship (Amendment) Bill, 2019, in the Lok Sabha, saying that the Bill tries to divide the country.

Speaking in the Lok Sabha, Owaisi said the Bill was not only the part of a conspiracy to make Indian Muslims stateless but would also lead to pose a risk to the national security.

Justifying his act to tear the Bill, Owaisi said that he was following the footprints of Mahatma Gandhi, who opposed the certificate which was issued to Asia-origin people in South Africa.

Addressing the Chair, he said: "You know madam how Mahatma Gandhi became Mahatma? He tore the national register card in South Africa. Since Mahatma tore that card, I am tearing this as it tries to divide the country."

"The government is hatching a conspiracy by the Citizenship (Amendment) Bill and the NRC (National Register of Citizens) to make Muslims stateless. I oppose this Bill as it is against the Constitution and an insult to our freedom fighters," he said.

During his speech, the AIMIM chief asked the Central government as to how many non-Muslims of Pakistan, Afghanistan and Bangladesh would be granted Indian citizenship under the Bill.

"This Bill has been brought so that one more partition can be done. This is worse than (Adolf) Hitler's law," he stated.

Cornering the government over the Bill, he further said: "It is certain that Taliban will come to power in Afghanistan, and when it happens, we will need Hazaras, Tajiks in India so that we can control strategically. But when they will come to power, India will lose its trump card."

"This is your strategy. I did not expect that you will commit such a blunder on strategic security," he added.

Earlier, while moving the Bill for the passage in the House, Home Minister Amit Shah denied that the Bill seeks to segregate people on religious line.

"There is no question of it doing injustice to anyone. With the passing of this Bill, lakhs of crores of people will get rid of torturous life and become citizens of India," he told the Lower House.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 23,2020

New Delhi, Apr 23: Union Information and Broadcasting Minister, Prakash Javadekar, on Thursday condemned the attack on Republic TV editor-in-chief Arnab Goswami saying that this is "against democracy".

"We condemn the attempt to attack renowned journalist Arnab Goswami. Essentially, we condemn every attack on any journalist. Because this is against democracy," the Union Minister said.

"It is really ironical that those who preach tolerance have become so intolerant. Therefore, we condemn this attempt. We appeal to the collective wisdom that this is undemocratic. As per present law, definitely, police takes action, if there is a complaint," said Javadekar.

Two persons were arrested on Thursday morning for allegedly attacking Republic TV editor-in-chief Arnab Goswami and his wife Samyabrata Ray in Mumbai.

Comments

fairman
 - 
Thursday, 23 Apr 2020

Javedkar is blind not to accept Arnab's venomous statement in deciding the nation. He is another shameless 

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 12,2020

New Delhi, May 12: Former Prime Minister Manmohan Singh, who was admitted to the AIIMS here after suffering reaction to a new medication, was discharged on Tuesday.

The 87-year-old Congress leader was discharged around 12:30 pm, hospital sources said.

Manmohan Singh was shifted to a private ward in the Cardio-Neuro tower on Monday night. He was also tested for Covid-19 and his results had come out negative, the sources said. The Congress leader was admitted to the hospital on Sunday evening after he complained of uneasiness.

The sources said that Singh had developed a reaction to a new medication and was admitted to AIIMS for observation and investigation.

Manmohan Singh is currently a Member of Rajya Sabha from Rajasthan. He was the prime minister between 2004 and 2014.

In 2009, Singh underwent a successful coronary bypass surgery at the AIIMS.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 30,2020

Hyderabad, Jun 30: Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

The Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response. Human clinical trials are scheduled to start across India in July 2020.

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.

The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.

Announcing the vaccine development milestone, Dr Krishna Ella, Chairman and Managing Director said: "We are proud to announce COVAXIN, India's first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine."

Dr Ella added, "The proactive support and guidance from CDSCO has enabled approvals to this project. Our R&D and Manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform."
Expedited through national regulatory protocols, the company accelerated its objective in completing the comprehensive pre-clinical studies. Results from these studies have been promising and show extensive safety and effective immune responses.

Speaking about Bharat Biotech's prowess, Suchitra Ella, Joint Managing Director said, "Our ongoing research and expertise in forecasting epidemics has enabled us to successfully manufacture a vaccine for the H1N1 pandemic."
"Continuing our focus on creating the only BSL-3 containment facilities for manufacturing and testing in India, Bharat Biotech is committed to advancing vaccine development as a matter of national importance to demonstrate India's strength in handling future pandemics," she added.

Bharat Biotech's track record in developing vero cell culture platform technologies has been proven in several vaccines for Polio, Rabies, Rotavirus, Japanese Encephalitis, Chikungunya and Zika.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.